Identification of PDZK4, a novel human gene with PDZ domains, that is upregulated in synovial sarcomas

Satoshi Nagayama1, Megumi Iiizumi, Toyomasa Katagiri

  • 1Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.

Oncogene
|April 13, 2004
PubMed

Insights

Researchers identified PDZK4 (PDZ domain-containing 4) as a novel gene upregulated in synovial sarcoma. Inhibiting PDZK4 suppressed tumor cell growth, suggesting it as a potential therapeutic target for synovial sarcoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Synovial sarcomas (SSs) are rare soft tissue tumors with poorly understood molecular mechanisms of carcinogenesis.
  • Previous studies aimed to identify genes involved in SS development.

Purpose of the Study:

  • To identify novel genes overexpressed in synovial sarcoma.
  • To investigate the role of the identified gene, PDZK4 (PDZ domain-containing 4), in SS cell proliferation.
  • To evaluate PDZK4 as a potential therapeutic target for synovial sarcoma.

Main Methods:

  • cDNA microarray analysis to detect differentially expressed genes in SS cells.
  • Northern blotting to assess PDZK4 transcript expression in normal human tissues.
  • Immunocytochemistry to determine the subcellular localization of the PDZK4 protein.
  • Small interfering RNA (siRNA) to inhibit PDZK4 expression in SS cells.
  • Functional assays to assess the impact of PDZK4 modulation on cell growth.

Main Results:

  • A novel transcript, PDZK4, was specifically upregulated in all 13 examined SS cases.
  • PDZK4 transcript was detected only in fetal brain among normal human tissues.
  • The PDZK4 gene product localized primarily beneath the plasma membrane.
  • siRNA-mediated inhibition of PDZK4 suppressed synovial sarcoma cell growth.
  • Exogenous PDZK4 expression promoted the growth of T98G and COS7 cells.

Conclusions:

  • Inappropriate PDZK4 expression is strongly implicated in the proliferation of synovial sarcoma cells.
  • PDZK4 represents a promising molecular target for the development of novel therapeutic strategies for synovial sarcoma.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...